Source: ScienceDaily Health
Summary
A new Rutgers study indicates that GLP-1 drugs, including Ozempic and Wegovy, may reduce the connection between impulsivity and violent behavior. Researchers caution that this finding does not establish a direct cause-and-effect relationship.
Why It Matters
These findings could reshape our understanding of how certain medications affect behavior, potentially offering new insights into managing aggressive impulses in at-risk populations. If further research supports these results, it might pave the way for innovative treatments targeting not only obesity but also behavioral issues tied to impulsivity.


